Skip to main content

Home/ Meningitis/ Group items tagged second

Rss Feed Group items tagged

akea482

Meningitis Research Foundation welcome introduction of new MenB vaccine to protect babies - 0 views

  • world’s first comprehensive vaccination programme for babies against meningococcal B (MenB) meningitis and septicaemia through the UK’s immunisation programme.
  • not already received any routine vaccinations should have MenB at the same time as their first and third routine infant vaccinations
  • who have already received their first dose of routine vaccinations should have MenB at the same time as their second and third routine infant vaccinations
  • ...2 more annotations...
  • Those who have already received their first and second dose of routine vaccinations should have MenB at the same time as their third routine infant vaccinations 
  • Booster of MenB should also be offered at 12-13 months
  •  
    meningitis research
evuvuu

Meningococcal Meningitis: Symptoms, Causes, Treatments, and Vaccines - 0 views

  • a rare but serious infection.
  • the membranes that cover the brain and spinal cord to become inflamed.
  • approximately 1,000 people in the U.S. get meningococcal
  • ...14 more annotations...
  • can be fatal or cause great
  • harm without prompt treatment;
  • about 15% of those who survive are left with disabilities that include deafness, brain damage, and neurological problems.
  • the symptoms of meningococcal meningitis
  • Bacteria and viruses are the two main causes of meningitis.
  • In children and teens, meningococcus is the most common cause of bacterial meningitis. In adults, it is the second most common cause.
  • may cause infection in a part of the body -- the skin, gastrointestinal tract, or respiratory tract, for instance.
  • then spread through the bloodstream to the nervous system
  • can also enter the nervous system directly after severe head trauma, surgery, or infection.
  • Symptoms of meningococcal meningitis may vary from case to case. The more common signs and symptoms include: General poor feeling Sudden high fever Severe, persistent headache Neck stiffness Nausea or vomiting Discomfort in bright lights Drowsiness or difficulty awakening Joint pain Confusion or other mental changes A reddish or purple skin rashis a very important sign to watch for.
  • may be a sign of blood poisoning.
  • does not turn white when you press a glass against it,
  • a medical emergency.
  • Other symptoms of meningitis or blood poisoning may include: Tense or bulging soft spot (in babies) High-pitched or moaning cry (in babies) Stiff, jerky movements or floppiness (in babies or toddlers) Irritability Fast breathing Lethargy or excessive sleepiness Blotchy skin, turning pale or blue Shivering, or cold hands and feet Seizure
shaneep110

Meningococcal meningitis - Prevention - 0 views

    • shaneep110
       
      The first paragraph and maybe the second/third are the only ones of value.
  • Meningococcal disease risk can be decreased by approximately 90% in household contacts of a patient by administration of antibiotics known to eradicate meningococcal carriage
    • shaneep110
       
      Meningococcal - Inflammation of the meninges due to infection with the bacterium Neisseria meningitidis.
  • hemoprophylaxis significantly decreased the risk of meningococcal disease for household contacts with a risk ratio of 0.11 for those receiving chemoprophylaxis
    • shaneep110
       
      chemoprophylaxis - the use of drugs to prevent disease.
  • ...17 more annotations...
  • This is based on a meta-analysis of 4 retrospective studies and one small trial with 1249 cases of meningococcal disease and more than 4200 household contacts
  • In the United States, antimicrobial chemoprophylaxis is the primary means for prevention of meningococcal disease among close contacts of a patient with invasive meningococcal disease
    • shaneep110
       
      antimicrobial - an agent that kills microorganisms or inhibits their growth. 
  • The number needed to treat to prevent a single secondary household case was 218
  • (Purcell et al 2004). T
  • herefore, chemoprophylaxis should be recommended for the index patient with meningococcal disease and all household contacts within 24 hours of diagnosis of the primary case.
  • There are no high quality experimental trials addressing control policies for meningococcal disease and no adequate studies of chemoprophylaxis in day care settings. Nevertheless, current management guidelines support chemoprophylaxis within 24 hours for all close contacts
  • Chemoprophylaxis administered more than 14 days after contact with an index case is probably of no value. Also, chemoprophylaxis does not protect against subsequent reacquisition of N meningitidis.
  • Close Contacts Warranting Chemoprophylaxis for Meningococcal Disease
    • shaneep110
       
      New Title: ways of transmission 
  • Persons having contact with patient’s oral secretions during 7 days prior to disease onset
  • -- Kissing -- Sharing of toothbrushes -- Sharing of eating utensils -- Mouth-to-mouth resuscitation -- Unprotected contact during endotracheal intubation
    • shaneep110
       
      Unprotected Sex
  • Persons at Low Risk for Whom Chemoprophylaxis is Not Recommended
    • shaneep110
       
      New Title: Low Risk People
  • Casual contact (eg, at school or work) without direct exposure to patient’s oral secretions Indirect contact only (ie, only contact is with a high-risk contact and not a case) Health care worker without direct exposure to patient’s oral secretions
  • Rifampin, ceftriaxone, and ciprofloxacin
    • shaneep110
       
      Rifampin - a reddish-brown antibiotic used chiefly to treat tuberculosis and leprosy. ceftriaxone - Treats infections caused by certain types of bacteria. This medicine is a cephalosporin antibiotic.  cephalosporin - any of a group of semisynthetic broad-spectrum antibiotics resembling penicillin. ciprofloxacin - This medicine is a quinolone antibiotic that treats infections and is given to people who have been exposed to anthrax. quinolone - any of a class of antibiotics used in treating a variety of mainly Gram-negative infections, and thought to be responsible for antibiotic resistance in some microbes. Gram-negative - a staining technique for the preliminary identification of bacteria, in which a violet dye is applied, followed by a decolorizing agent and then a red dye. The cell walls of certain bacteria
  • (Centers for Disease Control and Prevention 2000; 2001; Committee on Infectious Disease 2000).
  • azithromycin
    • shaneep110
       
      azithromycin - Treats bacterial infections. This medicine is a macrolide antibiotic. macrolide - any of a class of antibiotics containing a lactone ring, of which the first and best known is erythromycin. lactone - an organic compound containing an ester group -OCO- as part of a ring. erythromycin - an antibiotic used in the treatment of infections caused byan antibiotic used in the treatment of infections caused by Gram-positive bacteria. It is similar in its effects to penicillin. Gram-positive - a staining technique for the preliminary identification of bacteria, in which a violet dye is applied, followed by a decolorizing agent and then a red dye. The cell walls of certain bacteria.
  • nasopharyngeal
    • shaneep110
       
      nasopharyngeal - of or relating to or located near the nasopharynx nasopharynx - the upper part of the pharynx, connecting with the nasal cavity above the soft palate.
  • the drug of choice is rifampin, which is both effective and inexpensive. For young children rifampin can be administered with greater patient acceptance in a flavored syrup. Rifampin is not recommended for use in pregnant women. Rifampin may interfere with the efficacy of oral contraceptives, and some antiepileptic and anticoagulant medications. Rifampin may also stain the urine orange for a couple days and may stain soft contact lenses. Ciprofloxacin is also not recommended for use in pregnant women.
acerda265

Meningococcal | Community Settings Risk Factors | CDC - 0 views

  • College students, especially first-year college students living in residence halls, are at a slightly increased risk for meningococcal disease compared with other persons of the same age. Many states have adopted legislation requiring colleges to provide information on risks of meningococcal disease to incoming students and/or students residing on campus, and some have mandated vaccination for certain students, unless a vaccination waiver is provided.
  • College students, especially first-year college students living in residence halls, are at a slightly increased risk for meningococcal disease compared with other persons of the same age. Many states have adopted legislation requiring colleges to provide information on risks of meningococcal disease to incoming students and/or students residing on campus, and some have mandated vaccination for certain students, unless a vaccination waiver is provided.
  • First-year college students living in residence halls are recommended to be vaccinated with meningococcal conjugate vaccine
  • ...2 more annotations...
  • within 5 years
  • The risk for meningococcal disease among non-first-year college students is similar to that for the general population. However, the vaccine is safe and effective and therefore can be provided to non-first-year college students.
1 - 4 of 4
Showing 20 items per page